Proteasome inhibition and its therapeutic potential in multiple myeloma

Ajai Chari1, Amitabha Mazumder2, Sundar Jagannath11Mount Sinai School of Medicine, New York, NY, USA; 2New York University School of Medicine, New York, NY, USAAbstract: Due to an unmet clinical need for treatment, the first in class proteasome inhibitor, bortezomib, moved from drug discovery to FDA...

Full description

Saved in:
Bibliographic Details
Main Authors: Ajai Chari, Amitabha Mazumder, Sundar Jagannath
Format: article
Language:EN
Published: Dove Medical Press 2010
Subjects:
Online Access:https://doaj.org/article/bfa5dae794bc4d58b562ef9039d50e04
Tags: Add Tag
No Tags, Be the first to tag this record!